{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,16]],"date-time":"2025-09-16T16:29:30Z","timestamp":1758040170445,"version":"3.44.0"},"reference-count":28,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,7,1]],"date-time":"2022-07-01T00:00:00Z","timestamp":1656633600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,7,1]],"date-time":"2022-07-01T00:00:00Z","timestamp":1656633600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,7,1]],"date-time":"2022-07-01T00:00:00Z","timestamp":1656633600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,7,1]],"date-time":"2022-07-01T00:00:00Z","timestamp":1656633600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,7,1]],"date-time":"2022-07-01T00:00:00Z","timestamp":1656633600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,7,1]],"date-time":"2022-07-01T00:00:00Z","timestamp":1656633600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,7,1]],"date-time":"2022-07-01T00:00:00Z","timestamp":1656633600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100000272","name":"National Institute for Health and Care Research","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000272","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006512","name":"School of Medicine, Duke University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006512","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100013374","name":"NIHR School for Primary Care Research","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100013374","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["ajconline.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The American Journal of Cardiology"],"published-print":{"date-parts":[[2022,7]]},"DOI":"10.1016\/j.amjcard.2022.03.034","type":"journal-article","created":{"date-parts":[[2022,4,23]],"date-time":"2022-04-23T07:11:37Z","timestamp":1650697897000},"page":"12-19","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Treatment and Outcomes of Acute Myocardial Infarction in Patients With Polymyalgia Rheumatica With and Without Giant Cell Arteritis"],"prefix":"10.1016","volume":"174","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2315-0744","authenticated-orcid":false,"given":"Balamrit S.","family":"Sokhal","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9272-6906","authenticated-orcid":false,"given":"Andrija","family":"Mateti\u0107","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aditya","family":"Bharadwaj","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Toby","family":"Helliwell","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Abhishek","family":"Abhishek","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christian D.","family":"Mallen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9678-5222","authenticated-orcid":false,"given":"Mohamed O.","family":"Mohamed","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9241-8890","authenticated-orcid":false,"given":"Mamas A.","family":"Mamas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.amjcard.2022.03.034_bib0001","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1016\/j.mayocp.2020.04.044","article-title":"Acute myocardial infarction in autoimmune rheumatologic disease: a nationwide analysis of clinical outcomes and predictors of management strategy","volume":"96","author":"Mohamed","year":"2021","journal-title":"Mayo Clin Proc"},{"key":"10.1016\/j.amjcard.2022.03.034_bib0002","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/S0140-6736(12)60680-1","article-title":"Polymyalgia rheumatica","volume":"381","author":"Kermani","year":"2013","journal-title":"Lancet"},{"key":"10.1016\/j.amjcard.2022.03.034_bib0003","doi-asserted-by":"crossref","first-page":"E495","DOI":"10.1503\/cmaj.140266","article-title":"Risk of vascular events in patients with polymyalgia rheumatica","volume":"186","author":"Hancock","year":"2014","journal-title":"CMAJ"},{"key":"10.1016\/j.amjcard.2022.03.034_bib0004","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1093\/rheumatology\/kep303a","article-title":"Guidelines and Audit Working Group. BSR and BHPR guidelines for the management of polymyalgia rheumatica","volume":"49","author":"Dasgupta","year":"2010","journal-title":"Rheumatol (Oxf Engl)"},{"key":"10.1016\/j.amjcard.2022.03.034_bib0005","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1136\/hrt.2003.020180","article-title":"Use of oral glucocorticoids and risk of cardiovascular and cerebrovascular disease in a population based case-control study","volume":"90","author":"Souverein","year":"2004","journal-title":"Heart"},{"key":"10.1016\/j.amjcard.2022.03.034_bib0006","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.1003432","article-title":"Dose-dependent oral glucocorticoid cardiovascular risks in people with immune-mediated inflammatory diseases: a population-based cohort study","volume":"17","author":"Pujades-Rodriguez","year":"2020","journal-title":"PLoS Med"},{"key":"10.1016\/j.amjcard.2022.03.034_bib0007","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/j.thromres.2005.06.006","article-title":"Effects of short-term glucocorticoids on hemostatic factors in healthy volunteers","volume":"118","author":"Brotman","year":"2006","journal-title":"Thromb Res"},{"key":"10.1016\/j.amjcard.2022.03.034_bib0008","first-page":"1","article-title":"Corticosteroid adverse effects","author":"Yasir","year":"2021","journal-title":"In: StatPearls. Treasure Island: StatPearls;"},{"key":"10.1016\/j.amjcard.2022.03.034_bib0009","doi-asserted-by":"crossref","first-page":"1454","DOI":"10.1002\/art.24459","article-title":"Epidemiology of giant cell arteritis and polymyalgia rheumatica","volume":"61","author":"Gonzalez-Gay","year":"2009","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.amjcard.2022.03.034_bib0010","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1097\/MCA.0000000000000545","article-title":"Treatment and outcomes of type 2 myocardial infarction and myocardial injury compared with type 1 myocardial infarction","volume":"29","author":"Smilowitz","year":"2018","journal-title":"Coron Artery Dis"},{"key":"10.1016\/j.amjcard.2022.03.034_bib0011","doi-asserted-by":"crossref","first-page":"1301","DOI":"10.1002\/acr.21712","article-title":"Association between polymyalgia rheumatica and vascular disease: a systematic review","volume":"64","author":"Hancock","year":"2012","journal-title":"Arthritis Care Res (Hoboken)"},{"key":"10.1016\/j.amjcard.2022.03.034_bib0012","unstructured":"HCUP National Inpatient Sample (NIS). Healthcare Cost and Utilization Project (HCUP). 2012. Agency for Healthcare Research and Quality, Rockville, MD. www.hcup-us.ahrq.gov\/nisoverview.jsp"},{"key":"10.1016\/j.amjcard.2022.03.034_bib0013","unstructured":"SPSS IBM. Statistics for Macintosh, version 27.0. Armonk, N.Y., USA: IBM Corp."},{"key":"10.1016\/j.amjcard.2022.03.034_bib0014","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1136\/heartjnl-2015-308514","article-title":"Associations between polymyalgia rheumatica and giant cell arteritis and 12 cardiovascular diseases","volume":"102","author":"Pujades-Rodriguez","year":"2016","journal-title":"Heart"},{"key":"10.1016\/j.amjcard.2022.03.034_bib0015","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1007\/s00296-016-3557-5","article-title":"Polymyalgia rheumatica and risk of coronary artery disease: a systematic review and meta-analysis of observational studies","volume":"37","author":"Ungprasert","year":"2017","journal-title":"Rheumatol Int"},{"key":"10.1016\/j.amjcard.2022.03.034_bib0016","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1136\/hrt.2004.037481","article-title":"Giant cell arteritis and cardiovascular disease in older adults","volume":"91","author":"Ray","year":"2005","journal-title":"Heart"},{"key":"10.1016\/j.amjcard.2022.03.034_bib0017","doi-asserted-by":"crossref","first-page":"1802","DOI":"10.1016\/j.amjcard.2015.09.022","article-title":"Comparison of outcomes of patients With ST-segment elevation myocardial infarction treated by primary percutaneous coronary intervention analyzed by age groups (<75, 75 to 85, and >85 years); (results from the Bremen STEMI registry)","volume":"116","author":"Fach","year":"2015","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.amjcard.2022.03.034_bib0018","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1001\/archinternmed.2011.36","article-title":"Age and outcomes in ST-segment elevation myocardial infarction treated with primary percutaneous coronary intervention: findings from the APEX-AMI trial","volume":"171","author":"Gharacholou","year":"2011","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.amjcard.2022.03.034_bib0019","doi-asserted-by":"crossref","first-page":"1389","DOI":"10.1016\/j.amjcard.2004.02.036","article-title":"Effects of long-term prednisone (>or =5 mg) use on outcomes and complications of percutaneous coronary intervention","volume":"93","author":"Ellis","year":"2004","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.amjcard.2022.03.034_bib0020","first-page":"15","article-title":"Comparison between type-2 and type-1 myocardial infarction: clinical features, treatment strategies and outcomes","volume":"13","author":"L\u00f3pez-Cuenca","year":"2016","journal-title":"J Geriatr Cardiol"},{"key":"10.1016\/j.amjcard.2022.03.034_bib0021","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/j.ejim.2021.02.001","article-title":"Myocardial infarction during giant cell arteritis: a cohort study","volume":"89","author":"Greigert","year":"2021","journal-title":"Eur J Intern Med"},{"key":"10.1016\/j.amjcard.2022.03.034_bib0022","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1093\/rheumatology\/kev262","article-title":"Increased risk of cardiovascular disease in giant cell arteritis: a general population-based study","volume":"55","author":"Amiri","year":"2016","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.amjcard.2022.03.034_bib0023","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.berh.2012.12.004","article-title":"Cardiovascular disease due to accelerated atherosclerosis in systemic vasculitides","volume":"27","author":"Cohen Tervaert","year":"2013","journal-title":"Best Pract Res Clin Rheumatol"},{"key":"10.1016\/j.amjcard.2022.03.034_bib0024","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1056\/NEJMcp1214825","article-title":"Clinical practice. Giant-cell arteritis and polymyalgia rheumatica","volume":"371","author":"Weyand","year":"2014","journal-title":"N Engl J Med"},{"key":"10.1016\/j.amjcard.2022.03.034_bib0025","doi-asserted-by":"crossref","first-page":"2512","DOI":"10.1093\/rheumatology\/kez639","article-title":"Percutaneous coronary intervention outcomes in patients with rheumatoid arthritis, systemic lupus erythematosus and systemic sclerosis","volume":"59","author":"Martinez","year":"2020","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.amjcard.2022.03.034_bib0026","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1016\/j.bcp.2019.04.027","article-title":"Treatment of giant cell arteritis","volume":"165","author":"Gonz\u00e1lez-Gay","year":"2019","journal-title":"Biochem Pharmacol"},{"key":"10.1016\/j.amjcard.2022.03.034_bib0027","doi-asserted-by":"crossref","first-page":"1332","DOI":"10.1002\/art.20171","article-title":"Low-dose aspirin and prevention of cranial ischemic complications in giant cell arteritis","volume":"50","author":"Nesher","year":"2004","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.amjcard.2022.03.034_bib0028","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1016\/j.jclinepi.2011.08.002","article-title":"Administrative database research has unique characteristics that can risk biased results","volume":"65","author":"van Walraven","year":"2012","journal-title":"J Clin Epidemiol"}],"container-title":["The American Journal of Cardiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002914922003277?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002914922003277?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,11]],"date-time":"2025-09-11T06:42:36Z","timestamp":1757572956000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0002914922003277"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,7]]},"references-count":28,"alternative-id":["S0002914922003277"],"URL":"https:\/\/doi.org\/10.1016\/j.amjcard.2022.03.034","relation":{},"ISSN":["0002-9149"],"issn-type":[{"type":"print","value":"0002-9149"}],"subject":[],"published":{"date-parts":[[2022,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Treatment and Outcomes of Acute Myocardial Infarction in Patients With Polymyalgia Rheumatica With and Without Giant Cell Arteritis","name":"articletitle","label":"Article Title"},{"value":"The American Journal of Cardiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.amjcard.2022.03.034","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}